FDA regulation of medical devices, including the status of breast implants: joint hearing before the Subcommittee on Human Resources and Intergovernmental Relations and the Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, first session, August 1, 1995
United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on Human Resources and Intergovernmental Relations
U.S. Government Printing Office, 1996 - Breast implants - 206 pages
14 pages matching rupture rate in this book
Results 1-3 of 14
What people are saying - Write a review
We haven't found any reviews in the usual places.
advisory agency answer approval arthritis augmentation autoimmune disease BARRETT believe biomaterials breast augmentation breast cancer breast reconstruction BURLINGTON Chairman clinical cohort committee companies concern Congress Congressman connective tissue disease connective-tissue disease cosmetic decision developed documents Dow Corning Drug elastomers epidemiologic evaluation evidence fact FDA's Ganske going GUTKNECHT HAZLETON hearing hydrocephalus industry issue KESSLER litigation Lloyd look manufacturers mastectomy MclNTOSH medical devices MERKATZ moratorium MORELLA Norplant panel percent physicians plants plastic surgeons polyester polyethylene polyurethane prepared statement problem PTFE public health question Ransom reconstruction regulatory reported rheumatoid arthritis Rheumatology rupture rate Russano safety scientific scleroderma SHANKLIN SHAYS shunt sili silicone breast implants silicone gel silicone gel breast silicone gel implants silicone implants specific subcommittee surgery symptoms Tara testimony tests Thank tion Traficant women with breast women with implants Y-ME